Eco R1 Capital, LLC Revolution Medicines, Inc. Transaction History

Eco R1 Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$18.35 - $34.12 $99.9 Million - $186 Million	-5,445,284 Reduced 97.62%	132,579 $3.8 Million
Q3 2023 Nov 14, 2023	SELL	$25.17 - $35.05 $40.8 Million - $56.8 Million	-1,620,837 Reduced 22.52%	5,577,863 $154 Million
Q2 2023 Aug 14, 2023	BUY	$20.28 - $27.0 $37.4 Million - $49.9 Million	1,846,517 Added 34.5%	7,198,700 $193 Million
Q1 2023 May 15, 2023	BUY	$20.76 - $30.09 $18.5 Million - $26.9 Million	893,452 Added 20.04%	5,352,183 $116 Million
Q4 2022 Feb 14, 2023	BUY	$17.68 - $25.53 $47 Million - $67.8 Million	2,656,884 Added 147.45%	4,458,731 $106 Million
Q3 2022 Nov 14, 2022	SELL	$17.46 - $26.0 $43.2 Million - $64.4 Million	-2,476,222 Reduced 57.88%	1,801,847 $35.5 Million
Q2 2022 Aug 15, 2022	BUY	$14.54 - $27.17 $43.7 Million - $81.6 Million	3,003,972 Added 235.77%	4,278,069 $83.4 Million
Q1 2022 May 16, 2022	BUY	$17.31 - $26.4 $22.1 Million - $33.6 Million	1,274,097 New	1,274,097 $32.5 Million

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.